International Congress “Biotechnology: State of the Art and Perspectives”

The International Biotechnology Congress will be held in Moscow on February 20-22, 2016. Along with Biotech World 2017 international specialized exhibition of biotechnology, this event remains one of the few high-level scientific meetings of professionals in biotech industry.

The hosts of the Congress aim to discuss with participants all leading fundamental and practical research projects in biotechnology, issues related to implementation of scientific developments, encouragement of cooperation, etc.

Irina Ivushkina, OCT Project Manager, will take part in one of the sessions hosted by Primer Capital venture fund. As part of ‘Strategic development of biotech projects: working stages and tools’ panel discussion, Irina will cover aspects of strategy selection at the stage of clinical development, current approaches and relevant requirements.

The following speakers will also take part in the discussion:

  • Elizaveta Rozhdestvenskaya, COO Primer Capital: Strategy for working with investors in science-driven projects

  • Anastasiya Shtro, CEO ReCon: Effective registration strategy

  • Roman Kulikov, Head of Biotechnology in Agriculture and Industry Cluster of Biomedical Technologies, Skolkovo Fund: Instruments used by development institutions for biotech projects

  • Andrey Lomonosov: Co-head of Biomedicine, National Technology Initiative, HealthNet Project: Working with various biotech segments for industry development

  • Julia Smirnova, Chairman of the INVITRO Group Strategy Committee: Long-term planning, projection and tactical implementation approaches

The session will start on February 20 at 11 A.M. (Hall 4, Gostiny Dvor, Ilynka, 4, Moscow). Please follow the link to learn more about the congress and to sign up.

The Organizing Committee will also hold a contest for young scientists. It aims to support young researchers and encourage creativity in the field of scientific research. There will be three prizes awarded in this contest.